1Torok T J, Holman R C, Choba T L. Increasing mortality from thrombotic thrombocytopenic purpura in the United States-analysis of national mortality data. 1968-1991. Am J Hematol,1995,50:84-90.
2Dang C T, Magid M S,Weksler B, et al. Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura. Blood, 1999,93 :1264-1270.
3Furlan M, Robles R, Solenthaler M, et al. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood, 1997,89: 3097- 3103.
4Tsai H M, Lian C Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Eng J Med,1998,339:1585-1594.
5Remuzzi G, Galbusera M, Noris M, et al. yon Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood,2002,100: 778-785.
6Moore J C, Hayward C P M, Warkentin T E, et al.Decreased yon Willebrand factor protease activity associated with thrombocytopenic disorders. Blood, 2001,98:1842-1846.
7Bianchi V, Robles R, Alberio L, et al. yon Willebrand factor-Cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood,2002,100: 710-713.
8Gerritsen H E, Robles R, Lammie B, et al. Partial amino acid sequence of purified yon Willebrand factor-Cleaving protease. Blood, 2001,98 : 1654 - 1661.
9Zheng X, Chung D, Takayama T K,et al. Structure of von Willebrand factor-Cleaving protease(ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem, 2001,276:41059-41063.
10Elliott M A, Nichols W L. Thrombotic thromboeytopenic purpura, and hemolytic uremic syndrome. Mayo Clin Proc,2001,76: 1154-1162.
